BioSolutia’s executive team is comprised of clinicians, whose primary focus is to ensure that appropriate patients secure access to, and safely benefit from, prescribed specialty medications. To achieve these objectives, BioSolutia adopts a patient-centric approach to each project, ensuring that the patient experience is optimized from all perspectives, including the following considerations:
Comprehensive approach to minimize cost impact on patient access.
Selection of care setting(s) that promotes both patient safety and well as convenience.
Effective patient education and in-home clinical support when warranted.
Impactful programs to maximize patient adherence.
Vigilant design of REMS or monitoring programs to support patient safety.